NCT03796780View on ClinicalTrials.gov

Comparison of Extra-Virgin and Refined Olive Oil on Some Cardiovascular Risk Factors

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

October 1, 2019

Conditions
Cardiovascular Risk Factor
Interventions
DIETARY_SUPPLEMENT

Extra-Virgin Olive Oil

Daily consumption of 25 mL Extra-Virgin Olive Oil in adjunct to medical treatment for 6 weeks

DIETARY_SUPPLEMENT

Refined Olive Oil

Daily consumption of 25 mL Refined Olive Oil in adjunct to medical treatment for 6 weeks

Trial Locations (1)

Unknown

Rajaei Cardiovascular, Medical & Research Center, Tehran

All Listed Sponsors
collaborator

Shahid Beheshti University of Medical Sciences

OTHER

lead

Javad Nasrollahzadeh

OTHER

NCT03796780 - Comparison of Extra-Virgin and Refined Olive Oil on Some Cardiovascular Risk Factors | Biotech Hunter | Biotech Hunter